Data / Form D filings / CF ON3 Lifesciences Parent DST
CF ON3 Lifesciences Parent DST: Form D filings
CF ON3 Lifesciences Parent DST, a real estate company in New York, NY, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on February 28, 2023, reports $69.8 million sold of a $69.8 million offering to 116 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O CANTOR FITZGERALD INVESTORS, LLC, 110 EAST 59TH STREET, New York, NY, 10022
- Phone
- (212) 938-5000
- Industry
- Other Real Estate
- Entity type
- Other (Statutory Trust)
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1928276
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | Amendment | $69,800,000 | $69,800,000 | 116 | May 11, 2022 | sec.gov | |
| May 23, 2022 | New notice | $69,800,000 | $16,293,535 | $53,506,465 | 25 | May 11, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| N/A Cantor Fitzgerald Investors, LLC | Executive Officer | |
| N/A CF ON3 Lifesciences Depositor, LLC | Executive Officer | |
| N/A CF ON3 Lifesciences Parent Manager, LLC | Executive Officer | |
| N/A CF ON3 Lifesciences DST Manager, LLC | Executive Officer |
Other real estate companies in New York that filed recently
- CROWDFUNZ 627 LLC offering · Oct 30, 2026
- FREX Series II DST $951,840 · Oct 28, 2026
- BREX Net Lease Data Center I DST $17.3 million · Oct 28, 2026
- iCross MF LLC $2.9 million · Oct 27, 2026
- Outpost Partnership, LP offering · Oct 26, 2026
- BR Diversified Industrial Portfolio 7, DST $60.1 million · Oct 23, 2026
Every Form D from the week of Feb 27, 2023 · All recent filings in New York · All recent Other Real Estate filings
Read from SEC EDGAR. Amount sold is what CF ON3 Lifesciences Parent DST reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.